Overall rank by patents
#582
Across all tracked assignees
USPTO PatentsView assignee record - 769 granted patents across 61 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION).
The verdict
Axis holds 769 US patents across 61 technology areas, rank #582 of 50,000 tracked assignees.
Axis AB has been granted 769 US utility patents between 2015 and 2025, placing Axis AB at rank #582 across all assignees tracked by PlainPatent. This portfolio spans 61 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.8 claims per patent with primary concentration in H04N (PICTORIAL COMMUNICATION, e.g. TELEVISION). As a Foreign Corporation, Axis AB is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Axis sits between Chevron Phillips Chemical Company Lp (777 patents, rank #578) and Cochlear Limited (768 patents, rank #586) - the closest US assignees by grant volume. The composite Innovation Score of 58.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 481 grants, compared with 288 in the 2015–2019 window, a +67% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Axis AB's 9.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 61 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Axis AB against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Chevron Phillips Chemical Company LP
777 patents
SK Telecom Co., Ltd.
772 patents
HITACHI CONSTRUCTION MACHINERY CO., LTD.
771 patents
Novozymes A/S
770 patents
GlobalFoundries Singapore Pte. Ltd.
769 patents
Janssen Pharmaceuticals, Inc.
769 patents
MEDTRONIC MINIMED, INC.
769 patents
Axis AB
769 patents
Cochlear Limited
768 patents
What this shows Axis holds 769 patents at rank #582, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #582 in granted patent volume.
Other assignees with the most granted patents in Axis's primary technology class.
Axis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
59 Top 4% higher than 96% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 22 | 2.9% |
| 2016 | 30 | 3.9% |
| 2017 | 51 | 6.6% |
| 2018 | 102 | 13.3% |
| 2019 | 83 | 10.8% |
| 2020 | 120 | 15.6% |
| 2021 | 86 | 11.2% |
| 2022 | 65 | 8.5% |
| 2023 | 81 | 10.5% |
| 2024 | 62 | 8.1% |
| 2025 | 67 | 8.7% |
Top 15 of 61 technology areas
Overall rank by patents
#582
Across all tracked assignees
58.7 out of 100
How to use this portfolio
Axis's 769 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.